Steegmann Jl

457 total citations
9 papers, 142 citations indexed

About

Steegmann Jl is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Steegmann Jl has authored 9 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 2 papers in Genetics and 2 papers in Rheumatology. Recurrent topics in Steegmann Jl's work include Hematopoietic Stem Cell Transplantation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Steegmann Jl is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Steegmann Jl collaborates with scholars based in Spain, Poland and Italy. Steegmann Jl's co-authors include Rafael de la Cámara, Á Figuera, R. Arranz, Patricia Martin‐Regueira, Miguel Ángel Díaz, Enrique Granados, Adrían Alegre, Doris Lindoerfer, Michele Baccarani and Anna Turkina and has published in prestigious journals such as Leukemia, Bone Marrow Transplantation and RISalud Institutional Health Repository of Andalucía.

In The Last Decade

Steegmann Jl

9 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steegmann Jl Spain 6 133 62 41 30 26 9 142
Desiree De Lange Netherlands 3 147 1.1× 40 0.6× 78 1.9× 27 0.9× 19 0.7× 5 190
N. Pollicardo Italy 9 218 1.6× 108 1.7× 49 1.2× 46 1.5× 5 0.2× 15 237
Amado Karduss Colombia 5 109 0.8× 26 0.4× 57 1.4× 11 0.4× 17 0.7× 17 129
Caterina Buquicchio Italy 7 172 1.3× 62 1.0× 45 1.1× 9 0.3× 15 0.6× 13 231
Nadja Jäkel Germany 8 124 0.9× 106 1.7× 20 0.5× 44 1.5× 13 0.5× 12 183
Sabine Hertle Switzerland 5 139 1.0× 100 1.6× 33 0.8× 49 1.6× 6 0.2× 8 189
Feras Alfraih Saudi Arabia 8 63 0.5× 40 0.6× 24 0.6× 8 0.3× 13 0.5× 25 141
Stefana Impera Italy 6 85 0.6× 54 0.9× 35 0.9× 8 0.3× 24 0.9× 14 140
M-C Béné France 5 152 1.1× 27 0.4× 146 3.6× 9 0.3× 40 1.5× 9 223
J-H Dalle France 6 67 0.5× 20 0.3× 42 1.0× 18 0.6× 11 0.4× 8 105

Countries citing papers authored by Steegmann Jl

Since Specialization
Citations

This map shows the geographic impact of Steegmann Jl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steegmann Jl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steegmann Jl more than expected).

Fields of papers citing papers by Steegmann Jl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steegmann Jl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steegmann Jl. The network helps show where Steegmann Jl may publish in the future.

Co-authorship network of co-authors of Steegmann Jl

This figure shows the co-authorship network connecting the top 25 collaborators of Steegmann Jl. A scholar is included among the top collaborators of Steegmann Jl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steegmann Jl. Steegmann Jl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hernández‐Boluda, Juan Carlos, Fermín Sánchez‐Guijo, María Teresa Gómez‐Casares, et al.. (2016). Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study. RISalud Institutional Health Repository of Andalucía. 1 indexed citations
2.
Hoffmann, Verena, Michele Baccarani, Doris Lindoerfer, et al.. (2013). The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. Leukemia. 27(10). 2016–2022. 42 indexed citations
3.
Granados, Enrique, Rafael de la Cámara, Miguel Ángel Díaz, et al.. (2000). Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.. PubMed. 85(10). 1060–7. 45 indexed citations
4.
Jl, Steegmann, A Granda, Rafael de la Cámara, et al.. (1999). [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].. PubMed. 44(6). 456–63. 1 indexed citations
5.
Tomás, JF, Río Aguilar, Steegmann Jl, et al.. (1998). Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation. 22(1). 47–51. 24 indexed citations
6.
Jl, Steegmann, et al.. (1996). Study of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia.. PubMed. 18(2). 405–9. 10 indexed citations
7.
Arranz, R., et al.. (1994). Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.. PubMed. 13(4). 383–7. 13 indexed citations
8.
Jl, Steegmann, Lourdes Vázquez, Guillermo J. Pérez, et al.. (1991). Interferon alpha treatment of accelerated-phase chronic myeloid leukemia in relapse after bone marrow transplantation: a case with complete cytogenetic and molecular remission.. PubMed. 7(1). 65–7. 5 indexed citations
9.
Arranz, R., et al.. (1989). [Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].. PubMed. 184(3). 121–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Desiree De Lange Breakdown of academic impact, for papers by N. Pollicardo Breakdown of academic impact, for papers by Amado Karduss Breakdown of academic impact, for papers by Caterina Buquicchio Breakdown of academic impact, for papers by Nadja Jäkel Breakdown of academic impact, for papers by Sabine Hertle Breakdown of academic impact, for papers by Feras Alfraih Breakdown of academic impact, for papers by Stefana Impera Breakdown of academic impact, for papers by M-C Béné Breakdown of academic impact, for papers by J-H Dalle
Rankless by CCL
2026